» Articles » PMID: 36839636

3D Printing Technologies in Personalized Medicine, Nanomedicines, and Biopharmaceuticals

Abstract

3D printing technologies enable medicine customization adapted to patients' needs. There are several 3D printing techniques available, but majority of dosage forms and medical devices are printed using nozzle-based extrusion, laser-writing systems, and powder binder jetting. 3D printing has been demonstrated for a broad range of applications in development and targeting solid, semi-solid, and locally applied or implanted medicines. 3D-printed solid dosage forms allow the combination of one or more drugs within the same solid dosage form to improve patient compliance, facilitate deglutition, tailor the release profile, or fabricate new medicines for which no dosage form is available. Sustained-release 3D-printed implants, stents, and medical devices have been used mainly for joint replacement therapies, medical prostheses, and cardiovascular applications. Locally applied medicines, such as wound dressing, microneedles, and medicated contact lenses, have also been manufactured using 3D printing techniques. The challenge is to select the 3D printing technique most suitable for each application and the type of pharmaceutical ink that should be developed that possesses the required physicochemical and biological performance. The integration of biopharmaceuticals and nanotechnology-based drugs along with 3D printing ("nanoprinting") brings printed personalized nanomedicines within the most innovative perspectives for the coming years. Continuous manufacturing through the use of 3D-printed microfluidic chips facilitates their translation into clinical practice.

Citing Articles

Extrusion-Based 3D Printing of Pharmaceuticals-Evaluating Polymer (Sodium Alginate, HPC, HPMC)-Based Ink's Suitability by Investigating Rheology.

Rony F, Kimbell G, Serrano T, Clay D, Ilias S, Azad M Micromachines (Basel). 2025; 16(2).

PMID: 40047629 PMC: 11857113. DOI: 10.3390/mi16020163.


Evaluating Swellable Cross-Linked Biopolymer Impact on Ink Rheology and Mechanical Properties of Drug-Contained 3D-Printed Thin Film.

Rony F, Appiah J, Alawbali A, Clay D, Ilias S, Azad M Pharmaceutics. 2025; 17(2).

PMID: 40006550 PMC: 11858972. DOI: 10.3390/pharmaceutics17020183.


Advancing diagnostics and disease modeling: current concepts in biofabrication of soft microfluidic systems.

Casanova C, Casanova M, Reis R, Oliveira J In Vitro Model. 2025; 3(2-3):139-150.

PMID: 39872940 PMC: 11756457. DOI: 10.1007/s44164-024-00072-5.


Nanomedicines for Pulmonary Drug Delivery: Overcoming Barriers in the Treatment of Respiratory Infections and Lung Cancer.

Fernandez-Garcia R, Fraguas-Sanchez A Pharmaceutics. 2025; 16(12.

PMID: 39771562 PMC: 11677881. DOI: 10.3390/pharmaceutics16121584.


The Formulation and Evaluation of Customized Prednisolone Gel Tablets Prepared by an Automated Extrusion-Based Material Deposition Method.

Tihhonova M, Meos A, Airaksinen S, Aruvali J, Sandler Topelius N, Heinamaki J Pharmaceutics. 2025; 16(12.

PMID: 39771511 PMC: 11677990. DOI: 10.3390/pharmaceutics16121532.


References
1.
Goyanes A, Allahham N, Trenfield S, Stoyanov E, Gaisford S, Basit A . Direct powder extrusion 3D printing: Fabrication of drug products using a novel single-step process. Int J Pharm. 2019; 567:118471. DOI: 10.1016/j.ijpharm.2019.118471. View

2.
Lalatsa A, Statts L, de Jesus J, Adewusi O, Dea-Ayuela M, Bolas-Fernandez F . Topical buparvaquone nano-enabled hydrogels for cutaneous leishmaniasis. Int J Pharm. 2020; 588:119734. DOI: 10.1016/j.ijpharm.2020.119734. View

3.
Trenfield S, Tan H, Awad A, Buanz A, Gaisford S, Basit A . Track-and-trace: Novel anti-counterfeit measures for 3D printed personalized drug products using smart material inks. Int J Pharm. 2019; 567:118443. DOI: 10.1016/j.ijpharm.2019.06.034. View

4.
Garg S, Heuck G, Ip S, Ramsay E . Microfluidics: a transformational tool for nanomedicine development and production. J Drug Target. 2016; 24(9):821-835. DOI: 10.1080/1061186X.2016.1198354. View

5.
Dash A, Cudworth 2nd G . Therapeutic applications of implantable drug delivery systems. J Pharmacol Toxicol Methods. 1999; 40(1):1-12. DOI: 10.1016/s1056-8719(98)00027-6. View